Amy Mackey

Director, Patient Innovation & Engagement - Oncology Merck & Co

Seminars

Wednesday 6th May 2026
Designing for Measurable Patient Engagement: Building KPIs at the Start to Drive Trial Impact
11:00 am
  • Lessons from embedding patient input early in oncology trial design, and how “starting with the end in mind” enables measurable outcomes
  • Case reflections from KEYNOTE-355: tracking changes to study design, enrollment dynamics, and patient access outcomes
  • Implementing pre–post insight evaluation tools across global teams to quantify what internal and external stakeholders view as meaningful impact
  • Strategies for separating signal from noise when measuring impact in a complex trial environment with multiple confounders
Amy Mackey, Director of Patient Innovation & Engagement at Merck speaking at 3rd Measuring Patient Engagement Summit